Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie W C Hui

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative StudyEdwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Pageof 2